Related Experiment Video
Updated: Feb 26, 2026

Pulse Wave Velocity Testing in the Baltimore Longitudinal Study of Aging
Published on: February 7, 2014
Vascular Age: A narrative review of assessment methods, clinical applications, and future directions
Zisu Yang1, Xiaobo Wang2, Lihua Li1,3
1Department of Gerontology, The First Affiliated Hospital of Dali University, Jiashibo Road 32, Dali, 671000, Yunnan Province, China.
Insights
Vascular age (VA) offers a better measure of cardiovascular health than chronological age, improving risk assessment and patient communication. This review explores VA assessment methods and their clinical applications for cardiovascular disease prevention.
Area of Science:
- Cardiology
- Vascular Biology
- Preventive Medicine
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Traditional CVD risk models struggle with intermediate-risk stratification.
- Vascular age (VA) provides a biological measure of vascular health, potentially improving risk assessment and patient engagement.
Purpose of the Study:
- To review current methods for assessing vascular age (VA).
- To discuss clinical advances and applications of VA in cardiovascular disease (CVD) risk stratification.
- To explore emerging technologies and future directions for VA implementation.
Main Methods:
- Systematic review of literature on VA assessment.
- Analysis of techniques including arterial stiffness (e.g., pulse wave velocity), vascular structure (e.g., carotid intima-media thickness, coronary artery calcium score), and vascular function.
- Inclusion of emerging AI-based methods (e.g., deep learning from photoplethysmography, retinal images).
Main Results:
- VA integrates multiple risk factors and cumulative vascular damage.
- VA aids in stratifying intermediate-risk individuals and enhancing physician-patient communication.
- Applications include personalized treatment guidance and use in specific populations (diabetes, rheumatoid arthritis).
Conclusions:
- Vascular age represents a promising tool for enhancing cardiovascular disease risk assessment and management.
- Standardization of methods, reference values, and cost-effectiveness studies are needed for widespread clinical adoption.
- Future research should focus on technological innovation and clinical trial validation for practical VA implementation.
Abstract:
Cardiovascular disease (CVD) is the leading cause of death and disability globally, highlighting the importance of effective risk assessment and early intervention. However, traditional risk assessment models based on common risk factors have limitations, particularly for stratifying intermediate-risk individuals. Vascular age (VA), a biological marker combining multiple cardiovascular risk factors and cumulative damage to the vascular system, has gained increasing attention as a more intuitive understanding of vascular health than chronological age. This may facilitate clearer physician-patient communication, and promote lifestyle changes and treatment adherence. This review summarizes methods for assessing VA and recent clinical advances. It explains popular evaluation techniques, including those based on arterial stiffness (such as pulse wave velocity), vascular structure (e.g., carotid intima-media thickness, coronary artery calcium score), vascular function, and multifactorial risk-scoring models. Emerging technologies using artificial intelligence (e.g., deep learning) to estimate VA from photoplethysmography or retinal images are also discussed. The review highlights the role of VA in improving CVD risk stratification, improving patient communication and adherence, guiding personalized treatments, and its application to specific populations (including those with diabetes and rheumatoid arthritis). It emphasizes key concepts such as early vascular aging and supernormal vascular aging. Finally, current challenges are discussed, including the need for standardized assessment methods, establishment of reference values, and evaluation of cost-effectiveness. Future directions such as technological innovations, clinical trial designs, and practical applications are explored. By thoroughly analyzing existing evidence, this review provides a valuable reference for further research and clinical implementation of vascular age.
Related Concept Videos
The Effect of Aging on Tissues
Pharmacodynamics in Geriatric Patients: Effects of Age
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Assessment of the Cardiovascular System II: Inspection
Head and Neck

